CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
AvenCell Therapeutics, Inc.
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Dana-Farber Cancer Institute
Genmab
Ossium Health, Inc.
Lyell Immunopharma, Inc.
Essen Biotech
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
University of Ulm
Case Comprehensive Cancer Center
University of Rochester
UNC Lineberger Comprehensive Cancer Center
University Health Network, Toronto
Case Comprehensive Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Miltenyi Biomedicine GmbH
Caribou Biosciences, Inc.
Affiliated Hospital to Academy of Military Medical Sciences
Affiliated Hospital of Nantong University
Shanghai First Song Biotechnology Co., LTD
University of Birmingham
Chinese PLA General Hospital
Ruijin Hospital
The Affiliated People's Hospital of Ningbo University